Group 1 - The core viewpoint of the news is that Meihao Medical has seen a stock price increase of 5.27%, reaching 23.55 CNY per share, with a total market capitalization of 13.397 billion CNY as of the report date [1] - Meihao Medical, established on July 15, 2010, specializes in the design, development, manufacturing, and sales of precision components and products for medical devices, with its main revenue sources being home respiratory machine components (59.48%), home and consumer electronics components (14.61%), and other medical product components [1] - The company was listed on October 12, 2022, and has a trading volume of 101 million CNY and a turnover rate of 1.17% [1] Group 2 - Among the top circulating shareholders of Meihao Medical, Bosera Fund's Bosera Healthcare Mixed A (050026) has entered the top ten, holding 2.0095 million shares, which accounts for 1.29% of the circulating shares [2] - The fund has achieved a year-to-date return of 11.9% and a one-year return of 5.29%, ranking 5510 out of 8160 and 6755 out of 8026 in its category, respectively [2] - The fund manager, Chen Ximing, has been in position for nearly four years, with the fund's total asset size at 2.704 billion CNY [3]
美好医疗股价涨5.27%，博时基金旗下1只基金位居十大流通股东，持有200.95万股浮盈赚取237.12万元